Home Clinic 3D Treatment Cancer Enlarged Prostatitis Testimonials  Appointment   FAQ

Prostate Cancer

Prostate Cancer

Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are also cases of aggressive prostate cancers. The cancer cells may metastasize (spread) from the prostate to other parts of the body, particularly the bones and lymph nodes. Prostate cancer may initially cause no symptoms, but in later stages can cause pain, difficulty in urinating, problems during sexual intercourse, erectile dysfunction, among other symptoms and ultimately, death.

The presence of prostate cancer may be indicated by symptoms, physical examination, prostate-specific antigen (PSA), digital rectal examination (DRE), trans-rectal ultrasound (TRUS), or MRI.

Traditional treatment generally involves surgery, various forms of radiation therapy, proton therapy or, less commonly, cryosurgery; hormonal therapy and chemotherapy are generally reserved for cases of advanced disease. In addition, the traditional treatment can cause many additional side effects, such as sexual dysfunction, urinary incontinence, radiation enteritis, and so on.

3D Prostate Targeted Therapy has many superior features, not the least of which is its degree of non-invasiveness and the use of medicines which cause no side-effects. It is a superior, proven treatment protocol for prostate cancer.

  

The Causes of Prostate Cancer

Current medical view: a complete understanding of the causes of prostate cancer remains elusive. The primary risk factors are obesity, age and family history.

Dr. Song's view: prostate cancer is usually caused by various causative pathogens and various prostatic endotoxin.

Dr. Song found there are one or more specific pathogens for all prostate diseases in the development process. We can often find these bacteria in the patient's prostate, like Staphylococcus Aureus and Streptococcus can cause enlarged tonsil, and Streptococcus bovis can cause rectal cancer-like. Some causative pathogens (like virus, fungus, chlamydia, etc.) can directly damage the prostate cells, and raise the prostatic specific antigen( PSA) levels and may have a close relationship with prostate cancer. After removing these pathogens and prostatic endotoxin, the PSA value of a patient can return to normal with prostate nodules disappearing. In the past 20 years, prostatitis patients who have received our 3D Prostate Targeted Treatment rarely have suffered from prostate cancer after removing the pathogens and infections.

Prostatic endotoxin refers to harmful substances within the prostate. Prostatic endotoxin is divided into exotoxin and endotoxin. Exotoxin refers to external environment pollution, such as, air pollution, water pollution, and food pollution. Environment pollution brings harmful chemical materials, such as heavy metal cadmium can lead to prostate cancer. Endotoxin refers to harmful products created in the human body during the process of metabolism. These harmful products include: lactic acid, ketone acid, uric acid, and free radicals. Prostatic endotoxin also includes: biological toxins produced by pathogenic micro-organisms, excess fat, and old and dead cells within the prostate. Prostatic endotoxin can accumulate in the prostate through a variety of channels into the prostate, such as rectal spread, blood circulation, lymphatic circulation, and bladder urine backflow,etc . These endotoxins damage prostatic cells and tissues, irritate the urethra and nerves, and cause dysuria and male sexual dysfunction. When prostatic endotoxins continuously deposit in the prostate, they cause the prostate blockage, prostate calcification, and prostate cancer.

Prostate Cancer Symptoms

It is important to note that early prostate cancer usually causes no symptoms, however, sometimes, it does and these are often similar to diseases like benign prostatic hyperplasia. They include frequent urination, nocturia (increased urination at night), difficulty starting and maintaining a steady stream of urine, hematuria (blood in the urine), and dysuria (painful urination).

Prostate cancer is associated with urinary dysfunction as the prostate gland surrounds the prostatic urethra. Changes within the gland, therefore, directly affect urinary function. Because the vas deferens deposits seminal fluid into the prostatic urethra, and secretions from the prostate gland itself are included in semen content, prostate cancer may also cause problems with sexual function and performance, such as difficulty achieving erection or painful ejaculation.

Advanced prostate cancer can spread to other parts of the body, possibly causing additional symptoms. The most common is bone pain, often in the vertebrae (bones of the spine), pelvis, or ribs. Spread of cancer into other bones such as the femur is usually to the proximal part of the bone. Prostate cancer in the spine can also compress the spinal cord, causing leg weakness and urinary and fecal incontinence.

Prostate Cancer Pathophysiology

Prostate cancer is classified as an adenocarcinoma, or glandular cancer, that begins when normal semen-secreting prostate gland cells mutate into cancer cells. The region of the prostate gland where the adenocarcinoma is most common is the peripheral zone. Initially, small clumps of cancer cells remain confined to otherwise normal prostate glands, a condition known as carcinoma in situ or prostatic intraepithelial neoplasia (PIN). Although there is no proof that PIN is a cancer precursor, it is closely associated with cancer. Over time, these cancer cells begin to multiply and spread to the surrounding prostate tissue (the stroma) forming a tumor. Eventually, the tumor may grow large enough to invade nearby organs such as the seminal vesicles or the rectum, or the tumor cells may develop the ability to travel in the bloodstream and lymphatic system. Prostate cancer is considered a malignant tumor because it is a mass of cells that can invade other parts of the body. This invasion of other organs is called metastasis. Prostate cancer most commonly metastasizes to the bones, lymph nodes, and may invade rectum, bladder and lower ureters after local progression. The route of metastasis to bone is thought to be venous as the prostatic venous plexus draining the prostate connects with the vertebral veins.

Prostate Cancer Screening Tests and Clinical diagnosis

Cancer screening means looking for cancer before it causes symptoms. However, most prostate cancers grow slowly or not at all.

Two tests are commonly used to screen for prostate cancer:

1) Digital Rectal Examination (DRE): A doctor or nurse inserts a gloved, lubricated finger into the rectum to estimate the size of the prostate and feel for lumps or other abnormalities.

2) Prostate specific antigen (PSA) test: Measures the level of PSA in the blood. PSA is a substance made by the prostate. The levels of PSA in the blood can be higher in men who have prostate cancer.

If your prostate specific antigen (PSA) test or digital rectal exam (DRE) is abnormal, doctors may do more tests to find or diagnose prostate cancer.

Clinical diagnosis of prostate cancer mainly rely on Digital Rectal Examination (DRE), serum Prostate specific antigen (PSA) test , Trans-Rectal Ultrasound (TRUS), and pelvic Nuclear Magnetic Resonance Imaging (MRI) examination.

Normally a PSA>4 ug/L result is the critical value that is used to screen prostate cancer. When the PSA result is between 4 to 10ug/L, it is called the grey area, it can indicate prostate cancer or prostate enlargement. When the PSA result is over 10ug/L, the possibility of prostate cancer is almost certain. When checked by digital rectal examination (DRE) and transrectal ultrasound, and prostate nodules are detected, and PSA is over 10ug/L, a Nuclear Magnetic Resonance Imaging (MRI) examination is required to diagnose or exclude prostate cancer.

Prostate Biopsy: We are opposed to the transrectal prostate biopsy. We often find that these patients had prostate biopsy, their prostate growth very quickly. The doctors often do the transrectal prostate biopsy. The biopsy is done directly through the rectum guided by ultrasound. The transrectal prostate biopsy is (1) very painful, (2) have the danger of introducing new bacteria into the prostate, (3) damage rectal tissue, create rectal fissures, intestinal toxins will enter the prostate gland, (4) damage the prostate, and cause fibrous indurations, etc.

Staging and Treatment of Prostate Cancer in Current Medical

If prostate cancer is diagnosed, other tests are done to find out if cancer cells have spread within the prostate or to other parts of the body. This process is called staging. Whether the cancer is only in the prostate, or has spread outside the prostate, determines your stage of prostate cancer. The stage of prostate cancer tells doctors what kind of treatment you need.

There are two schemes commonly used to stage prostate cancer. The most common is promulgated by the American Joint Committee on Cancer, and is known as the TNM system, which evaluates the size of the tumor, the extent of involved lymph nodes, and any metastasis (distant spread) and also takes into account the cancer grade. As with many other cancers, these are often grouped into four stages (I–IV). Another scheme, often still used by clinicians, is the Whitmore-Jewett stage. Briefly, Stage I disease is cancer that is found incidentally in a small part of the sample when prostate tissue was removed for other reasons, such as benign prostatic hypertrophy, and the cells closely resemble normal cells and the gland feels normal to the examining finger. In Stage II more of the prostate is involved and a lump can be felt within the gland. In Stage III, the tumor has spread through the prostatic capsule and the lump can be felt on the surface of the gland. In Stage IV disease, the tumor has invaded nearby structures, or has spread to lymph nodes or other organs.

 

The normal treatment of the prostate cancer includes active surveillance, surgery, radiation therapy, Chemotherapy, Hormone therapy, or the comprehensive use of the above. As for the most suitable treatment, one should consider the extent of tumor invasion (also called a stage), the malignant degree of the cancer cells, PSA concentration in the blood, etc. At the same time, one must consider the patient's age, physical fitness, and respect their choice, as these treatment have serious side effects, such as erectile dysfunction, incontinence, etc. A person must find a balance between efficacy and quality of life when they choose a treatment.

3D Prostate Targeted Treatment For Prostate Cancer

For prostate cancer, our treatment consists of several steps. First, we determine the location and size of the prostate cancer lesions by Digital Rectal Examination (DRE), Trans Rectal UltraSound (TRUS), and pelvic Nuclear Magnetic Resonance Imaging (MRI) examination. And then we targeted inject a set of anti-cancer herbal extracts without any side effects into the prostate cancer lesion area in high concentrations by using 3D targeted injection technology, thus directly inhibiting and killing cancer cells, making the prostate cancerous tissue atrophy and necrotize. At the same time, we targeted inject unblocking herbal extracts without any side effects to resolve the pathogenic tissue and prostatic endotoxin, and discharge toxic substances. In addition, we use some other herbal extracts without any side effects to improve and restore prostate immunity and the blood circulation to prevent the recurrence of prostate cancer. Through 3D Prostate Targeted Treatment, the volume of the prostate cancer lesions will shrink or disappear, and the patient’s symptoms should be improved or disappear.

At the first and second clinical stages (I-II stages), prostate cancer lesion is only confined to the prostate capsule. At this time, we inject a set of anti-cancer herbal extracts and unblocking herbal extracts within the prostate cancer lesion for treatment. At the third clinical stage (III stage), prostate cancer lesion goes beyond the prostate capsule and invades neighboring tissues and organs like seminal vesicle, bladder neck etc. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion, and we also apply 3D targeted injection technology to put a set of anti-cancer treatment medications into adjacent seminal vesicle, the bladder neck and other neighboring tissues and organs for treatment. At the fourth clinical stage (IV stage), prostate cancer lesion spreads beyond the prostate by transferring lesions to distant bones, or even lungs, liver and adrenal gland. We targeted inject treatment medicines within the prostate capsule to treat the primary lesion; at the same time, we couple with systemic treatment and local targeted injection treatment of distant metastasis lesions. The treatment medications include anti-cancer herbal extracts, unblocking herbal extracts, and improving immunity herbal extracts. Our clinical use of medicines have no side effects.

Because prostate cancer normally happens in older people, the cancer nodules will press on the prostate tubes, ejaculatory ducts and posterior urethra, prostate cancer patients usually may also have prostatitis and genitourinary tract infection, 3D Prostate Targeted Treatment can treat these diseases at the same time. 3D Prostate Targeted Treatment is very suitable for prostate cancer patients who also have prostatitis and benign prostatic hyperplasia.

3D Prostate Targeted Treatment is an non-surgical method that causes no harm, no side-effects with no ongoing consequences of the original disease, to completely treat prostate cancer. 3D Prostate Targeted Treatment is not a long-term medicinal treatment and so it is the best treatment for prostate cancer as it causes no side-effects.

At present, 3D Prostate Targeted Treatment is not suitable for distant metastases of prostate cancer, including bone metastases, lung metastases, liver metastases and adrenal glands metastases.

A Successful Clinical Case of 3D Prostate Cancer Therapy

John Kennedy from USA is a former patient, and one of our successful prostatitis cases. He had a very severe case of prostatitis for over 14 years, which could not be killed by oral and IV antibiotics in the USA. In 2007, John Kennedy's prostatitis was cured by Dr. Song. You can read his story on our website under Testimonials.

Because John . Kennedy received multiple prostate transrectal injections in the United States in 2006, his rectal wall and prostate gland left a fibrous scar that could lead to prostate cancer. In 2016, his PSA test was more than 40 ng / ml, and MRI showed that he had prostate cancer.

  

In the course of treatment of prostate cancer lesions, John. Kennedy discharged a large number of harmful substances over a period of time. These harmful substances are included pathogens, prostatic endotoxin, shedding of cancer cells, blocked material, calcified material, and the necrotic substances of lesion tissues.

  

After receiving a course of 3D Prostate Cancer Targeted Treatment, MRI showed his prostate cancer lesions have disappeared.

Dr. John Kennedy's contact way:

China Tel: 86-18511504533,
Email: jkennedy1004@gmail.com  .


Complications   Causes Chlamydia Blockage Comparison Videos Doctors  Translation Visa

Contact Us

Tel: + 86-186-73216429

WhatsApp: +86-186-73216429

E-mail: prostatecure3d@gmail.com